{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T04:00:15Z","timestamp":1720238415468},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ijcard.2015.03.281","type":"journal-article","created":{"date-parts":[[2015,3,28]],"date-time":"2015-03-28T17:49:30Z","timestamp":1427564970000},"page":"63-65","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Genetic testing and antiplatelet treatment: Still way to go?"],"prefix":"10.1016","volume":"187","author":[{"given":"Evangelos","family":"Oikonomou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Papaioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Toutouzas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Latsios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerasimos","family":"Siasos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitris","family":"Tousoulis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.03.281_bb0005","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1161\/CIRCULATIONAHA.106.686048","article-title":"Incidence and predictors of drug-eluting stent thrombosis during and after discontinuation of thienopyridine treatment","volume":"116","author":"Airoldi","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.281_bb0010","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1016\/j.jacc.2005.07.041","article-title":"Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0015","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1016\/j.jacc.2005.07.056","article-title":"Clopidogrel effect on platelet reactivity in patients with stent thrombosis: results of the CREST Study","volume":"46","author":"Gurbel","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0020","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1093\/eurheartj\/ehl275","article-title":"Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation","volume":"27","author":"Geisler","year":"2006","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/eurheartj\/ehp402","article-title":"Early but not late stent thrombosis is influenced by residual platelet aggregation in patients undergoing coronary interventions","volume":"31","author":"Geisler","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0030","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/eurheartj\/ehn046","article-title":"Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation","volume":"29","author":"Price","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0035","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/ehjci\/jet088","article-title":"Relationship between aspirin\/clopidogrel resistance and intra-stent thrombi assessed by follow-up optical coherence tomography after drug-eluting stent implantation","volume":"14","author":"Park","year":"2013","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2015.03.281_bb0040","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.thromres.2008.10.007","article-title":"Impact of clopidogrel resistance on thrombotic events after percutaneous coronary intervention with drug-eluting stent","volume":"124","author":"Wang","year":"2009","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0045","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3760\/cma.j.issn.0366-6999.20121384","article-title":"Predictive value of antiplatelet resistance on early stent thrombosis in patients with acute coronary syndrome","volume":"126","author":"Li","year":"2013","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0050","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/CIR.0b013e31823a5596","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2015.03.281_bb0055","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.2459\/JCM.0b013e328364bd25","article-title":"Identifying responsiveness to oral P2Y12 receptor blockers: platelet function assays and genetic tests","volume":"14","author":"Valgimigli","year":"2013","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.ijcard.2015.03.281_bb0060","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.thromres.2011.03.018","article-title":"Evidence of increased platelet reactivity in the first six months after acute ST segment elevation myocardial infarction","volume":"128","author":"Scalone","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0065","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.clpt.2006.07.007","article-title":"Impact of P-glycoprotein on clopidogrel absorption","volume":"80","author":"Taubert","year":"2006","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0070","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1161\/CIRCULATIONAHA.109.851949","article-title":"Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes","volume":"119","author":"Mega","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.281_bb0075","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCULATIONAHA.109.885194","article-title":"Cytochrome 2C19*17 allelic variant, platelet aggregation, bleeding events, and stent thrombosis in clopidogrel-treated patients with coronary stent placement","volume":"121","author":"Sibbing","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.281_bb0080","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/j.ijcard.2013.01.040","article-title":"The impact of CYP2C19 genotype on cardiovascular events and platelet reactivity in patients with coronary artery disease receiving clopidogrel","volume":"168","author":"Tousoulis","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0085","doi-asserted-by":"crossref","first-page":"e516","DOI":"10.1016\/j.ijcard.2014.01.078","article-title":"The impact of AMPD1 gene polymorphism on vascular function and inflammation in patients with coronary artery disease","volume":"172","author":"Tousoulis","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0090","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJMoa1008410","article-title":"Effects of CYP2C19 genotype on outcomes of clopidogrel treatment","volume":"363","author":"Pare","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0095","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2174\/092986711794839151","article-title":"The role of the cytochrome P450 polymorphisms in clopidogrel efficacy and clinical utility","volume":"18","author":"Tousoulis","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0105","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(12)60161-5","article-title":"Point-of-care genetic testing for personalisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial","volume":"379","author":"Roberts","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.03.281_bb0110","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.jacc.2013.05.082","article-title":"Mechanisms affecting platelet response to antiplatelet therapy in patients with ST-segment elevation myocardial infarction","volume":"62","author":"Siasos","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.281_bb0115","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/j.jacc.2010.12.047","article-title":"Prospective evaluation of on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention relationship with gene polymorphisms and clinical outcome","volume":"57","author":"Campo","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.281_bb9000","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","article-title":"Bedside monitoring to adjust antiplatelet therapy for coronary stenting","volume":"367","author":"Collet","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315005203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315005203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T02:17:46Z","timestamp":1717813066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315005203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":24,"alternative-id":["S0167527315005203"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.281","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic testing and antiplatelet treatment: Still way to go?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.281","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}